Competitive Technologies, Inc. (CTCC) Extends Agreement for Calmare® Scrambler Therapy® Pain Treatment Device to Ten Years
7/6/2012 9:16:17 AM
FAIRFIELD, Conn., July 6, 2012 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) announced today that is has negotiated a five-year extension to its agreement for the Calmare® pain therapy device utilizing "Scrambler Therapy"® technology. The agreement with Professor Giuseppe Marineo and Delta Research & Development, dated April 1, 2011, provided a five-year term expiring March 30, 2016 which has now been extended to March 30, 2021.
comments powered by